Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
1 "Health status disparities"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Technology/Device
Article image
Current Status of Continuous Glucose Monitoring Use in South Korean Type 1 Diabetes Mellitus Population–Pronounced Age-Related Disparities: Nationwide Cohort Study
Ji Yoon Kim, Seohyun Kim, Jae Hyeon Kim
Diabetes Metab J. 2025;49(5):1040-1050.   Published online April 28, 2025
DOI: https://doi.org/10.4093/dmj.2024.0804
  • 8,272 View
  • 269 Download
  • 11 Web of Science
  • 14 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study aims to identify the status of continuous glucose monitoring (CGM) use among individuals with type 1 diabetes mellitus (T1DM) in South Korea and to investigate whether age-related disparities exist.
Methods
Individuals with T1DM receiving intensive insulin therapy were identified from the Korean National Health Insurance Cohort (2019–2022). Characteristics of CGM users and non-users were compared, and the prescription rates of CGM and sensor- augmented pump (SAP) or automated insulin delivery (AID) systems according to age groups (<19, 19–39, 40–59, and ≥60 years) were analyzed using chi-square tests. Glycosylated hemoglobin (HbA1c) levels and coefficients of variation (CV) among CGM users were also examined.
Results
Among the 56,908 individuals with T1DM, 10,822 (19.0%) used CGM at least once, and 6,073 (10.7%) used CGM continuously. Only 241 (0.4%) individuals utilized either SAP or AID systems. CGM users were younger than non-users. The continuous prescription rate of CGM was highest among individuals aged <19 years (37.0%), followed by those aged 19–39 years (15.8%), 40–59 years (10.7%), and ≥60 years (3.9%) (P<0.001 for between-group differences). Among CGM users, HbA1c levels decreased from 8.7%±2.4% at baseline to 7.2%±1.2% at 24 months, and CV decreased from 36.6%±11.9% at 3 months to 34.1%±12.7% at 24 months.
Conclusion
Despite national reimbursement for CGM devices, the prescription rates of CGM remain low, particularly among older adults. Given the improvements in HbA1c and CV following CGM initiation, more efforts are needed to increase CGM utilization and reduce age-related disparities.

Citations

Citations to this article as recorded by  
  • Efficacy and Safety of Stage 5 Connected Insulin Pens in Type 1 or Type 2 Diabetes: Randomized Controlled Trial Protocol (SMART-5 Study)
    Ji Yoon Kim, Nam Hoon Kim, Soo Heon Kwak, Chang Hee Jung, Eun Seok Kang, Jun Sung Moon, Sun Joon Moon, So Yoon Kwon, Jee Hee Yoo, Younghoon Kim, Tae-min Lee, Chung-il Yang, Jae Hyeon Kim, Sang-Man Jin
    Endocrinology and Metabolism.2026; 41(3): 393.     CrossRef
  • Association of perceived diabetes stigma with time below range <3.0 mmol/L and anxiety in adults with type 1 diabetes using continuous glucose monitoring
    Seohyun Kim, Soojin Park, Sang‐Man Jin, Jae Hyeon Kim, Gyuri Kim
    Diabetic Medicine.2026;[Epub]     CrossRef
  • Suboptimal adoption of diabetes technology despite coverage and the impact on glycemic outcomes in children and adolescents with type 1 diabetes in Hong Kong
    Sarah Wing-yiu Poon, Kwong-tat Chan, Betty Wai-man But, Shirley Man-yee Wong, Wing-in Yam, Pik-to Cheung, Wing-shan See, Suk-yan Chan, Ho-chung Yau, Eunice Wai Yu Wong, Lap Ming Wong, Antony Chun-cheung Fu, Elaine Yin-wah Kwan, Janez Heung-ching Tsui, Sin
    Journal of Pediatric Endocrinology and Metabolism.2026; 39(3): 251.     CrossRef
  • Preliminary clinical outcomes and adoption of continuous glucose monitoring following reimbursement implementation in patients with type 1 diabetes in Thailand
    Nichapa Yordsudueam, Nattakarn Numsriskulrat, Worapimon Lerdrassameethad, Pattayarporn Paleekul, Jutipond jitchana, Nitchakarn Laichuthai, Taninee Sahakitrungruang
    Annals of Pediatric Endocrinology & Metabolism.2026; 31(1): 66.     CrossRef
  • Challenges and Opportunities for Improving Care for Type 1 Diabetes in Older Adulthood
    Anna R. Kahkoska, Joshua J. Neumiller, Anastasia-Stefania Alexopoulos, Amlan Barik, Elbert S. Huang, Lori M. Laffel, Naushira Pandya, Christine Slyne, Elena Toschi, Ruth S. Weinstock, Medha Munshi
    Diabetes Care.2026; 49(4): 559.     CrossRef
  • Continuous glucose monitoring and risks of acute and chronic diabetes-related complications and mortality in adults with type 1 diabetes: a nationwide cohort study
    Ji Yoon Kim, Seohyun Kim, Jae Hyeon Kim
    Diabetologia.2026; 69(7): 1858.     CrossRef
  • Integrating Pharmacists into CGM-Enabled Digital Diabetes Care: Advancing Personalized and Data-Driven Management
    Xiaoxiao Chen, Gyeong Eon Kim, Nam Ah Kim, Kwang Joon Kim
    Healthcare.2026; 14(8): 1019.     CrossRef
  • Temporal trends in treatment-requiring microvascular complications in young-onset diabetes: A nationwide population-based study
    Hwa Young Kim, Eunjeong Ji, Jaehyun Kim
    Diabetes Research and Clinical Practice.2026; 238: 113349.     CrossRef
  • The National Health Insurance Support System for Diabetes Consumables and Management Devices in South Korea: Status, Challenges, and Policy Directions
    Okha Ryu, Yo Han Lee
    Health Insurance Review & Assessment Service Research.2026; 6(1): 46.     CrossRef
  • High Waist-to-Height Ratio Increases the Risk of Cardiovascular Outcomes in Adults with Type 1 Diabetes Mellitus: A Nationwide Cohort Study
    Kyeong-Jin Kim, Seohyun Kim, Rosa Oh, So Hyun Cho, Myunghwa Jang, You-Bin Lee, Gyuri Kim, Sang-Man Jin, Kyu Yeon Hur, Ji Yoon Kim, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2026; 50(4): 739.     CrossRef
  • Trends of insulin pump therapy and continuous glucose monitoring use among people with type 1 diabetes by institution and region in Japan during 2014 and 2022: an observational study using nationwide claims data
    Takuya Yamaoka, Takehiro Sugiyama, Kimikazu Kashiwagi, Takashi Furuno, Kouko Yamamoto, Kenjiro Imai, Noriko Ihana-Sugiyama, Yuichi Nishioka, Mitsuru Ohsugi, Kohjiro Ueki, Akira Shimada, Toshimasa Yamauchi
    Diabetes Research and Clinical Practice.2026; 239: 113462.     CrossRef
  • Retrospective Validation of a Stage 5 Decision Support Algorithm Using Clinical Trial Data From Stage 4 Smart Insulin Pens
    Jee Hee Yoo, Seohyun Kim, Younghoon Kim, Sang-Man Jin, Jae Hyeon Kim
    Journal of Diabetes Science and Technology.2026;[Epub]     CrossRef
  • Utilization and Impact of Diabetes Technology among Type 1 Diabetes Patients at a Tertiary Hospital in Thailand
    Jirawan Pongrujikorn , Jutipond Jitchana, Nitchakarn Laichuthai
    Journal of the ASEAN Federation of Endocrine Societies.2026;[Epub]     CrossRef
  • Sequential use of continuous glucose monitoring, with or without exercise trackers, significantly improves glycemic control in patients with type 2 diabetes
    Anushka Lahiri, Suan Tee Lim, Htike Kyu, Yock Young Dan, Chin Meng Khoo
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP